Memantine in the treatment of senile dementia of the Alzheimer type-Reference-Cited by-同舟云学术

Memantine in the treatment of senile dementia of the Alzheimer type

Published:1986-01 Issue:1 Volume:10 Page:87-93
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Fleischhacker W.Wolfgang,Buchgeher Astrid,Schubert Harald

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference33 articles.

1. Reduced levels of catecholamines in the brain and increased activity of monoamine oxydase in platelets in Alzheimer's disease: therapeutic implications;Adolfsson,1978

2. Increased platelet and brain MAO activity in dementia disorders of the Alzheimer type. c.f. Gottfries C.G. Amine metabolism in normal ageing and in dementia disorders;Adolfsson,1980

3. The impact of catecholamine research on medical science and practice;Carlsson,1978

4. Psychiatric disturbances in Parkinson's Disease;Celesia;Dis. Nerv. Syst.,1972

5. Neuropharmacological studies on D 145 (1,3 Dimethyl-5-Aminoadamantan);Costall;Psychopharmacologia (Berl.),1975

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NLRP3 inflammasome for neurodegenerative disorders;Molecular Psychiatry;2023-09-05

2. Hope or hype? Aducanumab as a magic bullet for Alzheimer’s disease;BIO Integration;2022-06-18

3. The synapse as a treatment avenue for Alzheimer’s Disease;Molecular Psychiatry;2022-04-20

4. Palliative care interventions in advanced dementia;Cochrane Database of Systematic Reviews;2021-09-28

5. Memantine for dementia;Cochrane Database of Systematic Reviews;2019-03-20